TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.2, ss.151-158, 2017 (SCI-Expanded)
Objective: Glucocorticoids (GCs) are the key drugs for the treatment of pediatric acute lymphoblastic leukemia (ALL). Herein, investigation of the relationship between the N363S and Bcl / polymorphisms of the GC receptor gene (NR3C1) and the side effects of GCs during pediatric ALL therapy was aimed.